Polymeric compositions and their production and uses

• US 6,031,037 A
• Filed: 01/20/1998
• Issued: 02/29/2000
• Est. Priority Date: 01/20/1997
• Status: Expired due to Fees

• Current Assignee: CIBA Specialty Chemicals Water Treatments Limited (BASF SE)
• Original Assignee: CIBA Specialty Chemicals Water Treatments Limited (BASF SE)
• Inventors: Ghafoor, Mark Sirfaraz, Johnson, Ian Michael, Skinner, Malcolm
• Primary Examiner(s): Boykin, Terressa M.
• Application Number:
  US09/008,999
• Time in Patent Office: 770 Days
• Field of Search: 524/388
• US Class Current: 524/388
• CPC Class Codes: C02F 1/56 Macromolecular compounds
• CPC Class Codes: C02F 2103/28 from the paper or cellulose industry
• CPC Class Codes: C02F 2209/09 Viscosity
• CPC Class Codes: C08L 2205/02 containing two or more polymers of the same C08L -group
• CPC Class Codes: C08L 2666/02 Organic macromolecular compounds, natural resins, waxes or and bituminous materials
• CPC Class Codes: C08L 2666/04 Macromolecular compounds according to groups C08L7/00 - C08L49/00, or C08L55/00 - C08L57/00; Derivatives thereof
• CPC Class Codes: C08L 33/062 Copolymers with monomers not covered by C08L33/06
• CPC Class Codes: C08L 33/14 of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen

Abstract

A stable, pourable, liquid composition contains 20 to 60% by weight of a blend of a water soluble high IV polymer and a water soluble low IV cationic coagulant polymer, is selected from polyamines, cationic dicyandiamide polymers and polymers of 70 to 100% ethylenically unsaturated cationic monomer with 0 to 30% by weight acrylamide, and contains 0.01 to 1 part by weight of a water soluble multi-hydroxy compound per part by weight of the coagulant polymer.

Claims

1. A stable, pourable, liquid composition containing 20 to 60% by weight of a blend of a water soluble high IV polymer and a water soluble low IV cationic coagulant polymer, wherein the water soluble high IV polymer is a non-ionic or cationic polymer of water soluble ethylenically unsaturated cationic monomer or monomer blend and has an apparent IV of at least 2 dl/g as determined by measurements at 25°

C. using a suspended level viscometer on solutions in a 1 molar sodium chloride solution buffered to a pH of 7.5 and is present in the composition in an amount of 3 to 40% by weight, the water soluble low IV cationic coagulant has an IV of below 1.5 dl/g as determined by measurements at 25°

C. using a suspended level viscometer on solutions in a 1 molar sodium chloride solution buffered to a pH of 7.5 and is selected from polyamines, cationic dicyandiamide polymers and polymers of 70 to 100% ethylenically unsaturated cationic monomer selected from the group consisting of diallyl dimethyl ammonium chloride, dialkyl amino alkyl (meth) acrylates (including acid addition salts and quaternary ammonium salts) and dialkyl amino alkyl (meth) acylamides (including acid addition salts and quaternary ammonium salts) with 0 to 30% by weight acrylamide, and is present in the composition in an amount of 5 to 40% by weight, and the composition has a Brookfield viscosity of less than 30,000 cps as measured using spindle 6 at 10 rpm at 25°

C. and is a dispersion of the high IV polymer in an aqueous phase which is an aqueous solution of low IV coagulant polymer and 0.01 to 1 part by weight of a water soluble multi-hydroxy compound per part by weight of the coagulant polymer.

2. A composition according to claim 1 in which the amount of multi-hydroxy compound is 1 to 10% by weight of the composition and 0.05 to 0.5 parts per part by weight of the coagulant polymer.

3. A composition according to claim 1 or claim 2 in which the multi-hydroxy compound is selected from glycerol and polyethylene glycol.

4. A composition according to any preceding claim in which the amount of the high IV polymer is 0.1 to 1 part per part by weight of the cationic coagulant.

5. A composition according to any preceding claim in which the amount of high IV polymer is 0.4 to 0.7 parts per part by weight of the cationic coagulant and is 5 to 20% by weight of the composition.

6. A composition according to any preceding claim in which the high IV polymer has apparent IV of 5 to 12 dl/g.

7. A composition according to any preceding claim in which the cationic monomer in the high IV polymer is a dialkylaminoalkyl (meth) -acrylate or -acrylamide as acid addition or quaternary salt.

8. A composition according to any preceding claim in which the cationic coagulant is selected from polyamines, cationic dicyandiamide polymers and polymers of 80 to 100% by weight DADMAC with 0 to 20% acrylamide.

9. A composition according to any preceding claim in which the aqueous solution also contains water soluble inorganic salt.

11. A composition according to any preceding claim in which the high IV polymer is a polymer of 0 to 100% acrylamide and 100 to 0% by weight of an ethylenically unsaturated cationic monomer and optionally ethylenically unsatruated anionic monojmer in an amount less than the amount of cationic monomer.

12. A composition according to any preceding claim in which the high IV polymer is a polymer of 50 to 100% acrylamide and 0 to 50% of the cationic monomer and is present in an amount of 3 to 30% by weight of the composition, and the amount of the coagulant is 5 to 40%.

13. A composition according to claim 12 in which the high IV polymer is a copolymer of 5 to 45 by weight ethylenically unsaturated water soluble cationic monomer and 95 to 55% by weight acrylamide.

14. A composition according to any preceding claim in which the composition is free of polymers containing hydrophobic groups which include alkyl containing 4 or more carbon atoms or aryl.

15. A process of making a composition according to any preceding claim comprising dissolving in the said aqueous phase the monomer or monomers which are to be polymerised to form the high IV polymer and then polymerising the monomers.

16. A process of flocculating and/or coagulating a suspension comprising dosing into the suspension a composition according to any of claims 1 to 14 or a dilute solution formed by diluting with water a composition according to any of claims 1 to 14.

10. A composition according to claim 10 in which the amount of inorganic salt is 0.5 to 15% by weight of the composition and is 0.01 to 2 parts per part by weight of the coagulant.